KIF1A Gene SPG30 Genetic Test
At DNA Labs UAE, we offer the KIF1A Gene SPG30 Genetic Test for individuals who may be experiencing symptoms associated with hereditary spastic paraplegia type 30 (SPG30). This test can help diagnose the condition and provide valuable information about the specific genetic changes involved.
Test Details
The KIF1A gene is associated with SPG30, a condition characterized by progressive weakness and stiffness in the lower limbs, leading to difficulty walking. Our NGS (Next-Generation Sequencing) genetic testing method allows us to analyze multiple genes simultaneously, including the KIF1A gene.
To perform the test, we require a DNA sample, which can be obtained through a blood or saliva sample. Our advanced sequencing technologies will then sequence the KIF1A gene to look for any mutations or variations that may be responsible for SPG30.
The cost of the KIF1A Gene SPG30 Genetic Test is 4400.0 AED.
Test Components
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the KIF1A Gene SPG30 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with KIF1A Gene SPG30.
Interpreting the Results
It’s important to note that genetic testing for SPG30 should be done in a clinical setting, under the guidance of a healthcare professional or genetic counselor. They can help interpret the results and provide information about the implications of a positive or negative test result.
For more information or to schedule a KIF1A Gene SPG30 Genetic Test, please contact DNA Labs UAE.
Test Name | KIF1A Gene SPG30 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KIF1A Gene SPG30 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1A Gene SPG30 |
Test Details |
The KIF1A gene is associated with a condition called hereditary spastic paraplegia type 30 (SPG30). This condition is characterized by progressive weakness and stiffness in the lower limbs, leading to difficulty walking. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SPG30, NGS genetic testing can be used to identify mutations or changes in the KIF1A gene that may be responsible for the condition. NGS genetic testing for SPG30 involves obtaining a DNA sample, typically through a blood or saliva sample, and then sequencing the KIF1A gene to look for any mutations or variations. The results of the test can help confirm a diagnosis of SPG30 and provide information about the specific genetic changes involved. It’s important to note that genetic testing for SPG30 is typically done in a clinical setting, under the guidance of a healthcare professional or genetic counselor. They can help interpret the results and provide information about the implications of a positive or negative test result. |